The spring issue of CHANCE looks at the economic impact of COVID-19 in the UK, the US intelligence career of Solomon Kullback, and bias in shared data.
pandemic
Education Advocacy: Bending the ‘Moral Arc of the Universe’ with Data for Good
Education advocacy has a special place in Data for Good, partly for addressing such an important issue and also for how it builds the future.
ICSA Symposium Panelists Offer Leadership Advice
As invited session panelists for the 2020 International Chinese Statistical Association Applied Statistics Symposium, eight statisticians and data scientists were asked to share their thoughts and advice on leadership.
BBSW 2020 Finds New Ways to Collaborate Virtually
While the pandemic prevented a face-to-face event in 2020, the Bay Area Biotech-Pharma Statistical Workshop held two virtual symposiums—both related to COVID-19.
Data for Good Can Drive COVID Vaccine Confidence
David Corliss says statisticians can help address the distrust of vaccines, a large challenge of this phase of the COVID-19 pandemic.
2021: A Year of Hope and Helping
ASA President Rob Santos thinks now, more than ever, we as statisticians and human beings need to support each other. He encourages you to join him in devoting the year 2021 to building community.
What a Year It Has Been!
ASA President Wendy Martinez shares her top 10 highlights from her term and says she ends this year with renewed appreciation of the ASA community.
Significance Allows Statistics to Tell COVID-19 Story
Significance issued an open call for contributions, asking statisticians and data scientists “to help us explain the statistics of COVID-19.”
ASA DataFest 2020: A Virtual Experience
The 2020 DataFest was held as a virtual data challenge in which students worked in teams to explore an impact of the COVID-19 global pandemic.
Pharma Executive Offers Thoughts About COVID-19
Dr. Amrit Ray, global president, R&D and Medical, Upjohn Division, Pfizer Inc., offers his thoughts about the COVID-19 pandemic and how to best protect yourself and your family.